Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP

home / authors / autumn-d-zuckerman-pharmd-bcps-aahivp-csp

Articles

Multisite Health-Systems Specialty Pharmacy Study Evaluates Adherence to Self-Administered Biologic Disease-Modifying Antirheumatic Drugs

Multisite Health-Systems Specialty Pharmacy Study Evaluates Adherence to Self-Administered Biologic Disease-Modifying Antirheumatic Drugs

Autumn D. Zuckerman, PharmD, BCPS, AAHIVP, CSP;Scott Canfield, PharmD, CSP;Lana Gerzenshtein, PharmD, BCPS, CSP;Katie Hosteng, PhD
May 5th 2022

High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.

Read More

Latest Updated Articles

Chronic lymphocytic leukemia -- Image credit: LASZLO | stock.adobe.com
Published: August 19th 2024 | Updated: September 15th 2024
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors
Image Credit: © Zhanna - stock.adobe.com
Published: September 4th 2024 | Updated: September 15th 2024
Insights Into Immunotherapies For Adults With TP53-Mutated Acute Lymphoblastic Leukemia
Image Credit: © Gefo- stock.adobe.com
Published: September 7th 2024 | Updated: September 15th 2024
Expanding Treatment Horizons for Sickle Cell Disease: Barriers, Innovations, and Future Directions
X-ray of breast cancer -- Image credit: peterschreiber.media | stock.adobe.com
Published: August 28th 2024 | Updated: September 15th 2024
Pharmacists Enhance Care for Patients With HR+/HER2– Breast Cancer on CDK4/6 Inhibitor Therapy
Man receiving vaccine -- Image credit: New Africa | stock.adobe.com
Published: July 25th 2024 | Updated: September 15th 2024
Research Results Show Promise Toward Development of a Universal Influenza Vaccine
Proud mature woman smile after vaccination with bandage on arm. Beautiful smiling senior woman 70s after receiving the coronavirus vaccine. Elderly lady getting immunization via anti-viral vaccine - Image credit: Jelena Stanojkovic | stock.adobe.com
Published: August 15th 2024 | Updated: September 15th 2024
Co-Administering RSV and Influenza Vaccines Could Provide Tolerable Immune Responses